Physician profile
Jeff A Simerville
NPI 1871575506
$1,230.70
in general payments reported to CMS, 2019-2025
15 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2021: $215 · 2022: $211 · 2023: $246 · 2024: $175 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.84 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $449.81 | 2019-2025 | Tria Firm, Lithovue |
| C. R. Bard, INC. & Subsidiaries | $180.22 | 2023-2024 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $134.65 | 2025 | Gemtesa |
| Astellas Pharma US INC | $118.14 | 2019-2021 | |
| Rochester Medical Corporation | $75.72 | 2022 | |
| Janssen Biotech, INC. | $61.00 | 2019 | |
| Pfizer INC. | $42.18 | 2022-2023 | |
| Abbvie INC. | $37.77 | 2023-2024 | Lupron Depot |
| Dendreon Pharmaceuticals LLC | $26.89 | 2023 | Provenge |
| 180 Medical, INC. | $22.67 | 2024 | Gentlecath |
| Laborie Medical Technologies Corp. | $22.62 | 2024 | Endosheath Technology |
| Olympus America INC. | $21.79 | 2025 | Itind System |
| Novartis Pharmaceuticals Corporation | $17.80 | 2025 | |
| Avanos Medical | $15.62 | 2023 | On-Q* Pump and Accessories |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Simerville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.